Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3, indicating an update to the page's revision rather than a modification to the clinical trial details.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now displays 'Results Submitted' where it previously showed 'No Results Posted,' indicating that trial results are in the submission/availability process. This marks a status update in the study record reflecting that results data have been prepared for posting.SummaryDifference0.0%

- Check26 days agoChange DetectedA Publications section has been added, including the Phase 3 SKYSCRAPER-06 article citation (JAMA Oncol. 2026) with DOI and author list, plus a note that publications are auto-filled from PubMed.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page’s footer/site release revision was updated from **v3.5.0** to **v3.5.3**.SummaryDifference0.0%

- Check69 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0. The study information remains unchanged.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.